Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistic. CA Cancer J Clin. 2021;71(1):7–33.
Chen S, Shen J, Zhao J, et al. Magnolol suppresses pancreatic cancer development in vivo and in vitro via negatively regulating TGF-β/Smad signaling. Front Oncol. 2020;10:597672. https://doi.org/10.3389/fonc.2020.597672.
Capello M, Bantis LE, Scelo G, et al. Sequential validation of blood-based protein biomarker candidates for early-stage pancreatic cancer. J Natl Cancer Inst. 2017. https://doi.org/10.1093/jnci/djw266.
Anastasiadou E, Jacob LS, Slack FJ. non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5–18.
Panni S, Lovering RC, Porras P, et al. Non-coding RNA regulatory networks. Biochim Biophys Acta Gene Regul Mech. 2020;1863(6): 194417.
Tay Y, Rinn J, Pandolfifi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–52.
Wang Z, Ji X, Gao L, et al. In silicocomprehensive analysis of a novel serum exosome-derived competitive endogenous RNA network for constructing a prognostic model for glioblastoma. Front Oncol. 2021;11:553594. https://doi.org/10.3389/fonc.2021.553594.
Xiao J, Lv C, Xiao C, et al. Construction of a ceRNA network and analysis of tumor immune infiltration in pancreatic adenocarcinoma. Front Mol Biosci. 2021;8:745409. https://doi.org/10.3389/fmolb.2021.745409.
Molibeli KM, Hu R, Liu Y, et al. Potential clinical applications of exosomal circular RNAs: more than diagnosis. Front Mol Biosci. 2021;8:769832. https://doi.org/10.3389/fmolb.2021.769832.
Gurung S, Perocheau D, Touramanidou L, et al. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal. 2021;19(1):47.
Bei Y, Das S, Rodosthenous RS, et al. Extracellular vesicles in cardiovascular theranostics. Theranos-tics. 2017;7(17):4168–82.
Xie Z, Gao Y, Ho C, et al. Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment. Gut. 2021;71(3):568–579.
Li S, Li Y, Chen B, et al. exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes. Nucleic Acids Res. 2018;01(04):46.
Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15–20.
Liu S, Xie X, Lei H, et al. Identification of key circRNAs/lncRNAs/miRNAs/mRNAs and pathways in preeclampsia using bioinformatics analysis. Med Sci Monit. 2019;05:25.
Jeggari A, Marks DS, Larsson E. miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics. 2012;28(15):2062–2063.
Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92-7.
LiJH,LiuS,ZhouH, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:92–97.
Liu M, Wang Q, Shen J, et al. Circbank: a comprehensive database for circRNA with standard nomenclature. RNA Biol. 2019;16(7):899–905.
Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
Cao H, Cheng HS, Wang JK, et al. A 3D physio-mimetic interpenetrating network-based platform to decode the pro and anti-tumorigenic properties of cancer-associated fibroblasts. Acta Biomater. 2021;09(15):132.
Zhang X, Shi S, Zhang B, et al. Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopess. Am J Cancer Res. 2018;8(3):332–53.
Jin H, Liu P, Wu Y, et al. Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer. Cancer Sci. 2018;109(9):2946–56.
Zhang Y, Liu Q, Zhang X, et al. Recent advances in exosome-mediated nucleic acid delivery for cancer therapy. J Nanobiotechnology. 2022;20(1):279.
Ansari MA, Thiruvengadam M, Venkidasamy B, et al. Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: current status and future perspectives. Semin Cancer Biol. 2022;86(Pt 2):678–96.
Tickner JA, Urquhart AJ, Stephenson SA, et al. Functions and therapeutic roles of exosomes in cancer. Front Oncol. 2014;4:127.
Szajnik M, Derbis M, Lach M, et al. Exosomes in plasma of patients with ovarian carcinoma: potential biomarkers of tumor progression and response to therapy. Gynecol Obstet (Sunny- vale). 2013;Suppl 4:3.
Erb U, Zöller M. Progress and potential of exosome analysis for early pancreatic cancer detection. Expert Rev Mol Diagn. 2016;16(7):757–67.
Fakih M, Ouyang M, Wang C, et al. Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome. J Clin Invest. 2019;129(10):4464–76.
Cheng C, Liu D, Liu Z, et al. Positive feedback regulation of lncRNA TPT1-AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer. Cancer Sci 2022;113(9):2986–3001.
Chen J, Li Q, An Y, et al. CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer. Int J Oncol. 2013;43(3):877–85.
Li Y, Li Y, Luo J, et al. FAM126A interacted with ENO1 mediates proliferation and metastasis in pancreatic cancer via PI3K/AKT signaling pathway. Cell Death Discov. 2022;8(1):248.
Zeng Y, Zhang H, Zhu M, et al. β-Hydroxyisovaleryl-Shikonin Exerts an Anti-tumor Effect on Pancreatic Cancer Through the PI3K/AKT Signaling Pathway. Front Oncol. 2022;12:904258. https://doi.org/10.3389/fonc.2022.904258.
Wu W, Li Q, Zhu Z, et al. HTR1D functions as a key target of HOXA10-AS/miR-340–3p axis to promote the malignant outcome of pancreatic cancer via PI3K-AKT signaling pathway. Int J Biol Sci. 2022;18(9):3777–94.
Zhou Y, Zhu Y, Dong X, et al. Exosomes derived from pancreatic cancer cells induce osteoclast differentiation through the miR125a-5p/TNFRSF1B pathway. Onco Targets Ther. 2021;14:2727–39.
Sohrabi E, Rezaie E, Heiat M, et al. An integrated data analysis of mRNA, miRNA and signaling pathways in pancreatic cancer. Biochem Genet. 2021;59(5):1326–58.
Shang M, Zhang L, Chen X, et al. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis. Discov Med. 2019;28(153):159–72.
Zhu H, Gao W, Li X, et al. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer. Pancreatology. 2021;21(3):589–98.
Treiber M, Schulz HU, Landt O, et al. Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer. J Mol Med (Berl). 2006;84(12):1015–22.
Fang J, Wang H, Liu Y, et al. High KRT8 expression promotes tumor progression and metastasis of gastric cancer. Cancer Sci. 2017;108(2):178–86.
Huang X, Liu F, Jiang Z, et al. CREB1 suppresses transcription of microRNA-186 to promote growth, invasion and epithelial-mesenchymal transition of gastric cancer cells through the KRT8/HIF-1α axis. Cancer Manag Res. 2020;12:9097–111.
Pistoni L, Gentiluomo M, Lu Y, et al. Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma. Carcinogenesis. 2021;42(8):1037–45.
Qiu J, Du Z, Wang Y, et al. Weighted gene co-expression network analysis reveals modules and hub genes associated with the development of breast cancer. Medicine (Baltimore). 2019;98(6):e14345. https://doi.org/10.1097/MD.0000000000014345.
Wang Z, Moresco P, Yan R, et al. Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attack. Proc Natl Acad Sci U S A. 2022;119(4):e2119436119. https://doi.org/10.1073/pnas.2119463119.
Li W, Li T, Sun C, et al. Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients. Mol Med. 2022;28(1):43.
Wang W, Lou W, Ding B, et al. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer. Aging (Albany NY). 2019;11(9):2610–27.
Eguchi D, Ohuchida K, Kozono S, et al. MAL2 expression predicts distant metastasis and short survival in pancreatic cancer. Surgery. 2013;154(3):573–82.
Zhang B, Xiao J, Cheng X, et al. MAL2 interacts with IQGAP1 to promote pancreatic cancer progression by increasing ERK1/2 phosphorylation[J]. Biochem Biophys Res Commun. 2021;05(21):554.
Du Y, Gu Z, Li Z, et al. Dynamic Interplay between structural variations and 3D genome organization in pancreatic cancer. Adv Sci (Weinh). 2022;9(18):e2200818. https://doi.org/10.1002/advs.202200818.
Wolpin BM, OReilly BM, Ko YJ, et al. Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer. Ann Oncol. 2013;24(7):1792–801.
Mohammed S, Sukumaran S, Bajgain P, et al. Improving chimeric antigen receptor-modified T cell function by reversing the immunosuppressive tumor microenvironment of pancreatic cancer. Mol Ther. 2017;25(1):249–58.
Bossow S, Grossardt C, Temme A, et al. Armed and targeted measles virus for chemovirotherapy of pancreatic cancer. Cancer Gene Ther. 2011;18:598–608.
Katari UL, Keirnan JM, Worth AC, et al. Engineered T cells for pancreatic cancer Treatment. HPB (Oxford). 2011;13:643–50.